Djibouti vs Latvia: HIV-positive TB patients on ART (antiretroviral therapy)
Djibouti
71.0%
in 2024
Latvia
70.0%
in 2017
Djibouti rank
124th
Latvia rank
125th
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Djibouti
- Latvia
How they compare
Djibouti currently reports 71.0% against 70.0% in Latvia, a difference of 1.0%.
The two have swapped places 4 times across 11 shared years of data; in 2005 it was Latvia ahead.
Djibouti ranks 124th and Latvia ranks 125th of 144 countries.
Latvia has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Djibouti | Latvia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 22.3% | 48.0% | 25.7% | Latvia |
| 2010s | 55.1% | 62.9% | 7.8% | Latvia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Djibouti or Latvia?
- Djibouti, at 71.0% against 70.0% in Latvia as of 2024.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Djibouti and Latvia?
- 1.0%, with Djibouti ahead.
- How many years of comparable data are there for Djibouti and Latvia?
- 11 years are reported by both, from 2005 to 2017.
- How do Djibouti and Latvia rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Djibouti ranks 124th and Latvia ranks 125th of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.